July 24, 2026
According to the experts that we spoke to, the death, which followed an intravenous NAD⁺ infusion that went catastrophically wrong, underscores the risks of unproven treatments and the need for rigorous longevity medicine. Earlier this week, Elizabeth Baron, a 27-year-old woman from New York City, died after receiving an intravenous infusion at a local “wellness...
September 02, 2025
Two people nearly died, and several more sought treatment, after receiving peptide injections at the last RAADfest in Las Vegas. We might not know what happened until the ongoing investigations are concluded, but we asked several experts to share their thoughts on the broader context of unproven “rejuvenation therapies.” The nightmare scenario Admittedly, progress in...
September 08, 2023
We are at an interesting time for our field, and at long last, some rejuvenation therapies are entering clinical trials. The approach of directly targeting the processes of aging in humans can finally be put to the test. While rejuvenation therapies that aim to prevent, stop, or even reverse aging and age-related diseases are gradually...
March 30, 2022
It seems bizarre that in 2022, some biotech companies interested in doing something about aging are still saying that they are not. Cellular rejuvenation seems to be the latest buzzword and an attempt to rebrand and escape the stigma of anti-aging. Genentech is another cellular rejuvenation company Recently, researchers at the Salk Institute, in collaboration...



